Skip to main content

Table 5 Incidence density rate for leishmaniosis in collared (G1) and uncollared control (G2) dogs calculated for each follow-up in the study

From: Efficacy of a slow-release imidacloprid (10%)/flumethrin (4.5%) collar for the prevention of canine leishmaniosis

Study day

Number of dogs in the cohort

Number of new cases

Dog-months of follow-up

Incidence density rate/year

G1

G2

G1

G2

G1

G2

G1

G2

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

(Site S1/Site S2)

Inclusion (D0)

102 (35/67)

117 (38/79)

-

-

-

-

-

-

I Follow-up (D90 ± 10)

102 (35/67)

117 (38/79)

0 (0/0)

15 (2/13)

299.9 (97.7/202.3)

341.6 (103.4/238.6)

0.0 (0.0/0.0)

52.7 (23.2/65.4)

II Follow-up (D180 ± 10)

91 (30/61)

100 (36/64)

2 (0/2)

2 (0/2)

273.9 (91.8/182.4)

308.0 (115.9/192.0)

8.8 (0.0/13.2)

7.8 (0.0/12.6)

III Follow-up (D210 ± 10)

86 (30/56)

95 (36/59)

0 (0/0)

25 (10/15)

81.7 (29.1/52.1)

89.30 (34.9/55.5)

0.0 (0.0/0.0)

336.0 (343.6/324.6)

IV Follow-up (D300 ± 10)

84 (30/54)

67 (26/41)

1 (0/1)

5 (3/2)

242.8 (87.0/155.5)

190.3 (75.4/115.2)

4.9 (0.0/7.7)

31.5 (47.8/20.8)

Total

  

3

47 (15/32)

898.3 (305.6/592.3)

929.2 (329.6/601.3)

4.0 (0.0/6.1)

60.7 (54.6/63.9)

  1. Site S1 = Messina shelter; Site S2 = Augusta shelter.